MGTX
MGTX
NASDAQ · Biotechnology

Meiragtx Holdings Plc

$13.25
+0.20 (+1.53%)
As of Sep 20, 10:23 PM ET ·
Financial Highlights (FY 2026)
Revenue
99.16M
Net Income
-139,143,661
Gross Margin
94.0%
Profit Margin
-140.3%
Rev Growth
+72.3%
D/E Ratio
1.08
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 94.0% 94.1% 65.8% 65.8%
Operating Margin -130.2% -117.2% -9.9% -11.8%
Profit Margin -140.3% -133.3% -10.4% -12.0%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 99.16M 57.56M 298.22M 353.14M
Gross Profit 93.26M 54.14M 196.30M 232.45M
Operating Income -129,108,325 -67,450,799 -29,566,882 -41,721,150
Net Income -139,143,661 -72,693,617 -30,982,952 -42,442,765
Gross Margin 94.0% 94.1% 65.8% 65.8%
Operating Margin -130.2% -117.2% -9.9% -11.8%
Profit Margin -140.3% -133.3% -10.4% -12.0%
Rev Growth +72.3% +72.3% -0.7% -1.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 325.32M 325.32M 274.26M 257.56M
Total Equity 301.36M 301.36M 356.05M 341.85M
D/E Ratio 1.08 1.08 0.77 0.75
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -128,746,349 -70,998,451 -39,492,333 -49,405,433
Free Cash Flow -35,501,473 -31,424,329